Myriad Genetics Inc (MYGN)
- Exchange
- NASDAQ
- Symbol
- MYGN
- Sector
- Life Sciences
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Description
- Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah.
- Country
- USA
Stock price
At close: July 10, 2025
-
Open5.71
-
High5.83
-
Low5.43
-
Close5.50
-
Volume1,381,830
Financial ratios
Dec 31, 2024